Clinical Trials · NCT04889183
SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- University Medical Center Groningen
- Enrollment
- 125
- Start date
- Mar 2022
- Locations
- 13 sites, 4 countries
- Primary endpoint
- Change from baseline to week 24 in urinary albumin:creatinine ratio (UACR)